ClinicalTrials.gg
CompletedNCT01928667Updated Jul 19, 2016

Case-Control Study to Identify Risk Factors for Microscopic Colitis

An observational study in Microscopic Colitis, Collagenous Colitis and Lymphocytic Colitis, sponsored by Maastricht University Medical Center. Completed at 1 site in Netherlands. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2016-07-19.

Sponsored by Maastricht University Medical Center · Observational

Study type
Observational
Model
Case-control
Time perspective
Retrospective
Enrollment
487
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of the study is to assess among others environmental and hygiene-related risk factors for microscopic colitis (MC), a common diarrheal disease.

02

Conditions studied

  • Microscopic Colitis
  • Collagenous Colitis
  • Lymphocytic Colitis

Browse trials for

03

In context

Colitis, Microscopic

23 studies on the registry are indexed under Colitis, Microscopic; 6 are open to participants now.

Browse Colitis, Microscopic studies →

Lead sponsor

Maastricht University Medical Center is the lead sponsor of 853 studies on the registry; 114 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The case group will be selected by a retropective search in the pathology registry. Subjects have to be diagnosed between January 1, 2000 and December 31, 2012; have to be older than 18 years of age and have to be living in the province of Limburg, the Netherlands.

Healthy controls are selected via the municipal personal records databases in the same region.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Confirmed Diagnosis of MC (CC or LC) between January 1, 2000 and December 31, 2012.
  • Inhabitant of the province of Limburg or the Eindhoven region at the moment of diagnosis

Exclusion criteria

Exclusion Criteria:

  • Below 18 years of age at the time of diagnosis
  • Not capable of signing an
  • Deceased at moment of approximation
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Case-control
Time perspective
Retrospective
Enrollment
487 participants (actual)
Patient registry
No
Biospecimen retention
Samples with dna

Groups and cohorts

  • Microscopic Colitis

    Group consists of subjects diagnosed with either collagenous of lymphocytic colitis between January 1, 2000 and December 31, 2012

    Other: Whole saliva sample

  • Healthy Controls

    Control group consists of subjects with no history of microscopic colitis. Group is age and sex matched with the case-group

    Other: Whole saliva sample

Interventions

  • OtherWhole saliva sample

    Both case and control group will be approached to consider to give permission to sample saliva. This is not obligatory. Collected samples will be stored for future DNA research.

06

What researchers measure

Primary outcomes

  1. Assessment of environmental and hygiene-related risk factors for microscopic colitis

    Information about environmental and hygiene-related risk factors is obtained by a questionnaire, sent to subjects diagnosed with MC between 2000 and 2012

    Time frame: Retrospective, between 2000 and 2012

Secondary outcomes

  1. The difference between the CC and LC subpopulation regarding environmental, hygiene-related, and generally known risk factors

    As generally known risk factors are considered: age, gender, medication, comorbidities and smoking. Information about risk factors is obtained by a questionnaire, sent to subjects diagnosed with MC between 2000 and 2012.

    Time frame: Retrospective between 2000 and 2012

07

Study locations

1 site
  • Maastricht UMC
    Maastricht, Limburg, Netherlands
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 19, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01928667
Responsible party
Sponsor
First posted
Aug 27, 2013
Start date
Jul 2014
Primary completion
Jun 2016
Completion
Jul 2016
Last update
Jul 19, 2016

Study contacts

Marieke J Pierik, MD, PhD
principal investigator · Maastricht UMC
Daisy MAE Jonkers, PhD
principal investigator · Maastricht University
Ad AM Masclee, Prof.
study director · Maastricht UMC

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion